The journey to understanding incretin systems: Theory, practice and more theory.

Published in: Journal of diabetes investigation (2019)

Accumulating clinical data on incretin-based dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists in the past decade have clearly confirmed their safety and efficacy as antidiabetes drugs. However, the journey to understand the incretin system and its role in health and disease continues.

Keyphrases

healthcare
public health
primary care
mental health
electronic health record
health information
health promotion
social media
deep learning